These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9616875)

  • 1. Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus.
    Parr EL; Bozzola JJ; Parr MB
    J Reprod Immunol; 1998 Apr; 38(1):15-30. PubMed ID: 9616875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2.
    Parr EL; Parr MB
    J Virol; 1997 Nov; 71(11):8109-15. PubMed ID: 9343160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice.
    Parr MB; Harriman GR; Parr EL
    Immunology; 1998 Oct; 95(2):208-13. PubMed ID: 9824477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract.
    Milligan GN; Bernstein DI
    Virology; 1995 Jan; 206(1):234-41. PubMed ID: 7831778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
    Gallichan WS; Rosenthal KL
    Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2.
    Parr EL; Parr MB
    J Virol; 1998 Jun; 72(6):5137-45. PubMed ID: 9573285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
    Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
    J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone increases susceptibility and decreases immune responses to genital herpes infection.
    Kaushic C; Ashkar AA; Reid LA; Rosenthal KL
    J Virol; 2003 Apr; 77(8):4558-65. PubMed ID: 12663762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2.
    Parr EL; Parr MB
    Immunology; 1999 Dec; 98(4):639-45. PubMed ID: 10594699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal immunity in the HSV-2 mouse model.
    Parr MB; Parr EL
    Int Rev Immunol; 2003; 22(1):43-63. PubMed ID: 12710503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
    Yan Y; Hu K; Deng X; Guan X; Luo S; Tong L; Du T; Fu M; Zhang M; Liu Y; Hu Q
    J Immunol; 2015 Jul; 195(1):329-38. PubMed ID: 25994965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice.
    Parr MB; Parr EL
    Immunology; 2000 Sep; 101(1):126-31. PubMed ID: 11012763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.
    Gallichan WS; Rosenthal KL
    Vaccine; 1995 Nov; 13(16):1589-95. PubMed ID: 8578847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization.
    Gallichan WS; Rosenthal KL
    J Infect Dis; 1998 May; 177(5):1155-61. PubMed ID: 9592997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection.
    Hendrickson BA; Guo J; Brown I; Dennis K; Marcellino D; Hetzel J; Herold BC
    Virology; 2000 May; 271(1):155-62. PubMed ID: 10814580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.
    Parr MB; Parr EL
    J Virol; 1998 Apr; 72(4):2677-85. PubMed ID: 9525585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.
    Gallichan WS; Woolstencroft RN; Guarasci T; McCluskie MJ; Davis HL; Rosenthal KL
    J Immunol; 2001 Mar; 166(5):3451-7. PubMed ID: 11207303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
    Gillgrass AE; Ashkar AA; Rosenthal KL; Kaushic C
    J Virol; 2003 Sep; 77(18):9845-51. PubMed ID: 12941893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
    Parr MB; Parr EL
    Virology; 1999 Jun; 258(2):282-94. PubMed ID: 10366565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.